Landstar System Inc. (Nasdaq:LSTR) reported 2010 fourth quarter net income of $24.1 million, or $0.50 per diluted share, compared to net income of $18.6 million, or $0.37 per diluted share, for the 2009 fourth quarter. Revenue for the 2010 fourth quarter was $587.5 million compared to $547.7 million in the 2009 fourth quarter.
Landstar System, Inc. is a non-asset based provider of integrated supply chain solutions. Landstar delivers safe, specialized transportation, warehousing and logistics services to a broad range of customers worldwide utilizing a network of agents, third-party capacity owners and employees.
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
Alzheimer's disease is among the most well known form of dementia, a broad term when it comes to forgetfulness and other intellectual abilities critical enough to obstruct everyday life. Alzheimer's diseases is the reason for 50 to 70 percent of dementia cases.
Parkinson's disease (PD) is part of a team of ailments known as motor system disorders, which are the result of the loss of dopamine-producing brain cells. The 4 fundamental symptoms of PD are tremor, or moving in hands, arms, legs, jaw, and face; hardness, or perhaps tightness of your limbs and trunk; bradykinesia, or slowness to move; and postural lack of stability, or inable sense of balance and also co-ordination. As far as signs and symptoms, they are more noticable, patients might have trouble walking, talking, or finishing many other very simple tasks.
Soon after skin cancer, cancer of the breast is easily the most widespread cancers recognized in females in the United States. But breast cancer rates have fallen in recent times, although medical professionals are not certain why. Even now, for numerous women of all ages, breast cancer could be the condition they will fear most.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials.
Global Hunter Corp. (TSX.V: BOB) (FSE:G5D) has built an outstanding portfolio of projects in the stable geopolitical geographies of Canada and Chile. Global Hunter’s exploration and development teams are on the ground rapidly advancing the La Corona de Cobre property near La Serena, Chile and the Rabbit South property in British Columbia, Canada. Either one of these projects could carry the company forward on a stand-alone basis, but together they bring the company additional stability, strength and value.
Global Hunter’s La Corona de Cobre project is over 18,000 hectares of land located in the Coast Range of the Andean Cordillera, Chile, an area often referred to as the Chilean Iron Belt. The property is on the Pan American Highway, 70-kilometres north of the port city La Serena.
The property is located at the southern end of the Atacama Fault Zone, a north-northeast regional feature that stretches for over 1,000 kilometres and hosts several large copper deposits in Chile including Phelps Dodge’s Candelaria (400 million tonnes grading 0.95% copper and 0.2% gold) and Anglo-American’s Manto Verde (100 million tonnes averaging 0.80% copper) deposits.
The main uses of copper are in the construction industry. Copper is used for plumbing, roofing and cladding. Copper is a light and durable metal that helps build maintenance free structures. It has anti-microbial properties that helps in providing hygienic surfaces in hospitals and other healthcare facilities.
Global Hunter’s Rabbit South molybdenum project is located within a prolific mining region in the Dominic and Roper Lake area, 27 kilometres west-southwest of the city of Kamloops British Columbia. The property is accessible year round by a combination of highway and logging roads. Rabbit South is situated 25 kilometres northeast of Highland Valley, BC’s largest porphyry copper mine (1.4 billion tonnes @ 0.40% Cu) and 12 kilometres southwest of Afton, BC’s richest porphyry copper mine (107Mi tonnes @ 1.05% Cu, 0.70g/t Au).
The area has been the subject of molybdenum exploration dating back to 1960. Between 1979 and 1981 an extensive exploration program including 69 percussion drill holes and 10 diamond drill holes identified the Roper Lake Molybdenum Target. A non-code-complaint resource of 65 million tonnes at 0.065% of Molybdenum was identified in two zones. Zone A measures 600 metres in length and is 300 meters wide by 60 metres deep, while Zone B has been outlined for 500 metres in length, 400 metres in width and 70 metres in depth.
Molybdenum's strength and resistance to expanding or softening at high temperatures is particularly sought after in critical areas where high temperatures are common, such as in nuclear power plants and aircraft engines.
For More Information Go To: www.globalhunter.ca
Acme Packet, Inc. (Nasdaq:APKT) the leader in session border control solutions, announced that Dr. Russell Muirhead has been appointed to the Company’s Board of Directors effective immediately. “We are delighted to have Russ join the Board of Directors,” said Mr. Andrew D. Ory, President and Chief Executive Officer of Acme Packet, Inc. “He has nearly 25 years of experience in the academic fields of government, modern leadership and public ethics. His insights on global politics and public policy will be invaluable as we expand the reach for our solutions within federal, state, and local government. We look forward to Russ’s contributions and counsel as we as we prepare for the next stage of the Company’s growth.”
Acme Packet, the leader in session border control solutions, enables the delivery of trusted, first-class interactive communications—voice, video and multimedia sessions—and data services across IP network borders. For more information visit www.acmepacket.com.
Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2010 on Thursday, February 10, 2011 before the financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio web cast on Thursday, February 10, 2011, at 10:00 a.m. Eastern Time (NYSE:ET). To participate in this conference call, dial 719-457-2735, confirmation code 6342085 shortly before 10:00 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 719-457-0820, confirmation code 6342085. The audio web cast can be accessed at: www.alexionpharma.com.
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products in the United States, Europe, Latin America, Japan, and the Asia Pacific. The company was founded in 1992 and is headquartered in Cheshire, Connecticut.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from Global Hunter Corp. (TSX Venture Exchange (TSX.V:BOB) and the Frankfurt Stock Exchange (FSE:G5D)) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company.